Sun J, Chen M, Hu Z, Xu N, Wang W, Ping Z
Nat Commun. 2024; 15(1):5778.
PMID: 38987259
PMC: 11237007.
DOI: 10.1038/s41467-024-50223-1.
Visconte C, Fenoglio C, Serpente M, Muti P, Sacconi A, Rigoni M
Int J Mol Sci. 2023; 24(19).
PMID: 37834197
PMC: 10572781.
DOI: 10.3390/ijms241914749.
You Y, Liu H, Zhu Y, Zheng H
Amino Acids. 2023; 55(4):421-442.
PMID: 36781451
DOI: 10.1007/s00726-023-03245-w.
Pensalfini A, Umar A, Glabe C, Parker I, Ullah G, Demuro A
Cells. 2022; 11(22).
PMID: 36429057
PMC: 9688564.
DOI: 10.3390/cells11223630.
Tuerkova A, Kabelka I, Kralova T, Sukenik L, Pokorna S, Hof M
Elife. 2020; 9.
PMID: 32167466
PMC: 7069690.
DOI: 10.7554/eLife.47946.
Alzheimer's Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts.
Fabiani C, Antollini S
Front Cell Neurosci. 2019; 13:309.
PMID: 31379503
PMC: 6657435.
DOI: 10.3389/fncel.2019.00309.
Dietary Modulation of Oxidative Stress in Alzheimer's Disease.
Thapa A, Carroll N
Int J Mol Sci. 2017; 18(7).
PMID: 28753984
PMC: 5536070.
DOI: 10.3390/ijms18071583.
Dissecting Complex and Multifactorial Nature of Alzheimer's Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective.
Talwar P, Sinha J, Grover S, Rawat C, Kushwaha S, Agarwal R
Mol Neurobiol. 2015; 53(7):4833-64.
PMID: 26351077
DOI: 10.1007/s12035-015-9390-0.
The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.
Walsh P, Vanderlee G, Yau J, Campeau J, Sim V, Yip C
J Biol Chem. 2014; 289(15):10419-10430.
PMID: 24554723
PMC: 4036164.
DOI: 10.1074/jbc.M113.515866.
The glaucoma-associated olfactomedin domain of myocilin forms polymorphic fibrils that are constrained by partial unfolding and peptide sequence.
Hill S, Donegan R, Lieberman R
J Mol Biol. 2013; 426(4):921-35.
PMID: 24333014
PMC: 3946817.
DOI: 10.1016/j.jmb.2013.12.002.
Bilayer measurement of endoplasmic reticulum Ca2+ channels.
Bezprozvanny I
Cold Spring Harb Protoc. 2013; 2013(11).
PMID: 24184754
PMC: 4317291.
DOI: 10.1101/pdb.top066225.
Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation.
Sciacca M, Kotler S, Brender J, Chen J, Lee D, Ramamoorthy A
Biophys J. 2012; 103(4):702-10.
PMID: 22947931
PMC: 3443794.
DOI: 10.1016/j.bpj.2012.06.045.
Alzheimer Aβ peptide interactions with lipid membranes: fibrils, oligomers and polymorphic amyloid channels.
Tofoleanu F, Buchete N
Prion. 2012; 6(4):339-45.
PMID: 22874669
PMC: 3609060.
DOI: 10.4161/pri.21022.
Modes of Aβ toxicity in Alzheimer's disease.
Gotz J, Eckert A, Matamales M, Ittner L, Liu X
Cell Mol Life Sci. 2011; 68(20):3359-75.
PMID: 21706148
PMC: 3181413.
DOI: 10.1007/s00018-011-0750-2.
Antimicrobial protegrin-1 forms ion channels: molecular dynamic simulation, atomic force microscopy, and electrical conductance studies.
Capone R, Mustata M, Jang H, Arce F, Nussinov R, Lal R
Biophys J. 2010; 98(11):2644-52.
PMID: 20513409
PMC: 2877344.
DOI: 10.1016/j.bpj.2010.02.024.
Activation of group III metabotropic glutamate receptor reduces intracellular calcium in beta-amyloid peptide [31-35]-treated cortical neurons.
Zhao L, Zhao S, Qian Z, Zhang C, Wu X, Du F
Neurotox Res. 2009; 16(2):174-83.
PMID: 19526293
DOI: 10.1007/s12640-009-9068-3.
Kinetic study of beta-amyloid residue accessibility using reductive alkylation and mass spectrometry.
Ramos I, Fabris D, Qi W, Fernandez E, Good T
Biotechnol Bioeng. 2009; 104(1):181-92.
PMID: 19418563
PMC: 2716430.
DOI: 10.1002/bit.22367.
An update on the toxicity of Abeta in Alzheimer's disease.
Gotz J, Ittner L, Schonrock N, Cappai R
Neuropsychiatr Dis Treat. 2009; 4(6):1033-42.
PMID: 19337449
PMC: 2646638.
DOI: 10.2147/ndt.s3016.
Do amyloid oligomers act as traps for misfolded proteins? A hypothesis.
Gruschus J
Amyloid. 2008; 15(3):160-5.
PMID: 18925454
PMC: 2575656.
DOI: 10.1080/13506120802193746.
Neurosteroids block the increase in intracellular calcium level induced by Alzheimer’s β-amyloid protein in long-term cultured rat hippocampal neurons.
Kato-Negishi M, Kawahara M
Neuropsychiatr Dis Treat. 2008; 4(1):209-18.
PMID: 18728806
PMC: 2515900.
DOI: 10.2147/ndt.s2059.